Literature Collection

1801

Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People

Type: Journal Article

Authors: Kate M. Lillie, Jennifer Shaw, Kelley J. Jansen, Michelle M. Garrison

Year: 2021

Publication Place: Baltimore, Maryland

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

1802

Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial spread to 107 rural and urban Alberta emergency departments

Type: Journal Article

Authors: K. D. Stone, K. Scott, B. R. Holroyd, E. Lang, K. Yee, N. Taghizadeh, J. Deol, K. Dong, J. Fanaeian, M. Ghosh, K. Low, M. Ross, R. Tanguay, P. Faris, N. Day, P. McLane

Year: 2023

Topic(s):

Reference Links:

Export Citation: RIS

View details

1803

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

Type: Journal Article

Authors: Lynn E. Sullivan, Brent A. Moore, Marek C. Chawarski, Michael V. Pantalon, Declan Barry, Patrick G. O'Connor, Richard S. Schottenfeld, David A. Fiellin

Year: 2008

Topic(s):

Export Citation: RIS

View details

1804

Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals

Type: Journal Article

Authors: F. D. Law, A. M. Diaper, J. K. Melichar, S. Coulton, D. J. Nutt, J. S. Myles

Year: 2017

Publication Place: United States

Abstract: Buprenorphine/naloxone, methadone and lofexidine are medications with utility in the treatment of opiate withdrawal. We report the first randomised controlled trial to compare the effects of these two medications on withdrawal symptoms and outcome during opiate induction/stabilisation and detoxification. A double-blind randomised controlled trial was conducted in an outpatient satellite clinic of a specialist drug service. Eighty opiate dependent individuals meeting DSM-IV criteria for opiate dependence, using (1/2) g heroin smoked/chased or (1/4) g heroin injected or 30mg methadone, with 3 years of opioid dependency, underwent a short-term opiate treatment programme involving induction/stabilisation on methadone 30mg or buprenorphine/naloxone 4mg/1mg, followed by detoxification (where the methadone group was assisted by lofexidine). The main outcome measures were urine drug screens for opiates and withdrawal and craving questionnaires. There were no overall differences in positive urine drug screens and drop-outs during any phase of the study. During induction/stabilisation, withdrawal symptoms subsided more slowly for buprenorphine/naloxone than for methadone, and craving was significantly higher in the buprenorphine/naloxone group ( p<0.05, 95% confidence interval -3.5, -0.38). During detoxification, withdrawal symptoms were significantly greater and the peak of withdrawal was earlier for the methadone/lofexidine group than the buprenorphine/naloxone group ( p<0.01, 95% confidence interval 3.0, 8.3). Methadone/lofexidine and buprenorphine/naloxone had comparable outcomes during rapid outpatient stabilisation and detoxification in low dose opiate users.

Topic(s):

Reference Links:

Export Citation: RIS

View details

1805

Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals

Type: Journal Article

Authors: F. D. Law, A. M. Diaper, J. K. Melichar, S. Coulton, D. J. Nutt, J. S. Myles

Year: 2017

Publication Place: United States

Abstract: Buprenorphine/naloxone, methadone and lofexidine are medications with utility in the treatment of opiate withdrawal. We report the first randomised controlled trial to compare the effects of these two medications on withdrawal symptoms and outcome during opiate induction/stabilisation and detoxification. A double-blind randomised controlled trial was conducted in an outpatient satellite clinic of a specialist drug service. Eighty opiate dependent individuals meeting DSM-IV criteria for opiate dependence, using (1/2) g heroin smoked/chased or (1/4) g heroin injected or 30mg methadone, with 3 years of opioid dependency, underwent a short-term opiate treatment programme involving induction/stabilisation on methadone 30mg or buprenorphine/naloxone 4mg/1mg, followed by detoxification (where the methadone group was assisted by lofexidine). The main outcome measures were urine drug screens for opiates and withdrawal and craving questionnaires. There were no overall differences in positive urine drug screens and drop-outs during any phase of the study. During induction/stabilisation, withdrawal symptoms subsided more slowly for buprenorphine/naloxone than for methadone, and craving was significantly higher in the buprenorphine/naloxone group ( p<0.05, 95% confidence interval -3.5, -0.38). During detoxification, withdrawal symptoms were significantly greater and the peak of withdrawal was earlier for the methadone/lofexidine group than the buprenorphine/naloxone group ( p<0.01, 95% confidence interval 3.0, 8.3). Methadone/lofexidine and buprenorphine/naloxone had comparable outcomes during rapid outpatient stabilisation and detoxification in low dose opiate users.

Topic(s):

Reference Links:

Export Citation: RIS

View details

1806

Burden and nutritional deficiencies in opiate addiction- systematic review article

Type: Journal Article

Authors: S. Nabipour, Ayu Said, Hussain Habil

Year: 2014

Publication Place: Iran

Abstract: Addiction to the illicit and prescribed use of opiate is an alarming public health issue. Studies on addictive disorders have demonstrated severe nutritional deficiencies in opiate abusers with behavioral, physiological and cognitive symptoms. Opiate addiction is also link with a significant number of diseases including Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV) and other blood borne diseases generally stem from the use of needles to inject heroin. The use of medication assisted treatment for opioid addicts in combination with behavioural therapies has been considered as a highly effective treatment. Methadone is a long-lasting mu-opioid agonist and a pharmacological tool which attenuates withdrawal symptoms effectively replacement therapies. This review article aims to explain opiate addiction mechanisms, epidemiology and disease burden with emphasis on dietary and nutritional status of opiate dependent patients in methadone maintenance therapy.

Topic(s):

Reference Links:

Export Citation: RIS

View details

1807

Burden of medical illness in drug- and alcohol-dependent persons without primary care

Type: Journal Article

Authors: I. De Alba, J. H. Samet, R. Saitz

Year: 2004

Topic(s):

Export Citation: RIS

View details

1808

Burnout among behavioral health providers in integrated care settings

Type: Journal Article

Authors: M. Zubatsky, C. Runyan, S. Gulotta, J. R. Knight, J. D. Pettinelli

Year: 2020

Publication Place: United States

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

1809

Burnout in Primary Care—Assessing and Addressing it in Your Practice

Type: Web Resource

Authors: Agency for Healthcare Resarch and Quality

Year: 2023

Publication Place: Rockville, MD

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (1.55 MB)

Reference Links: PDF (1.55 MB)

Export Citation: RIS

View details

1810

C-L case conference: Chronic psychosis managed in collaborative care

Type: Journal Article

Authors: Molly Howland, Denise Chang, Anna Ratzliff, Katherine Palm-Cruz

Year: 2021

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

1811

C2C Roadmap to Behavioral Health

Type: Web Resource

Authors: Centers for Medicare and Medicaid Services

Year: 2024

Publication Place: Baltimore, MD

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (641 KB)

Reference Links: PDF (641 KB)

Export Citation: RIS

View details

1812

CA Bridge Study Finds Emergency Department Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Type: Report

Authors: CA Bridge

Year: 2024

Publication Place: Oakland, CA

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

1813

California PCPs coordinate Medi-Cal behavioral health

Type: Journal Article

Authors: Stephanie Skernivitz

Year: 2010

Topic(s):

,

Export Citation: RIS

View details

1814

California primary care, mental health, and substance use services integration policy initiative

Type: Report

Year: 2009

Publication Place: Sacramento, CA

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

1815

California primary care, mental health, and substance use services integration policy initiative Volume III: Examples for Dissemination

Type: Government Report

Year: 2009

Publication Place: Sacramento, CA

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (6941.23 KB)

Reference Links: PDF (6941.23 KB)

Export Citation: RIS

View details

1816

California primary care, mental health, and substance use services integration policy initiative: Volume II - Working Papers

Type: Government Report

Year: 2009

Publication Place: Sacramento, CA

Topic(s):

, , , , ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Export Citation: RIS

View details

1817

Campaign to Stop Youth Opioid Abuse

Type: Web Resource

Authors: Truth Initiative

Year: 2018

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

1818

Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study

Type: Journal Article

Authors: M. Dwight-Johson, K. Ell, P. J. Lee

Year: 2005

Abstract: Abstract: In a pilot study, 55 low-income Latina patients with breast or cervical cancer and comorbid depression were randomly assigned to receive collaborative care as part of the Multifaceted Oncology Depression Program or usual care. Relative to patients in the usual care condition, patients receiving collaborative care were more likely to show>or=50% improvement in depressive symptoms as measured by the Personal Health Questionnaire (OR=4.51, 95% CI=1.07-18.93). Patients in the collaborative care program were also more likely to show improvement in emotional well-being (increase of 2.15) as measured by the Functional Assessment of Cancer Therapy Scale than were those receiving usual care (decrease of 0.50) (group difference=2.65, 95% CI: 0.18-5.12). Despite health system, provider, and patient barriers to care, these initial results suggest that patients in public sector oncology clinics can benefit from onsite depression treatment.

Topic(s):

Reference Links:

Export Citation: RIS

View details

1819

Can depression treatment in primary care reduce disability? A stepped care approach

Type: Journal Article

Authors: E. H. Lin, M. Von Korff, J. Russo, W. Katon, G. E. Simon, J. Unutzer, T. Bush, E. Walker, E. Ludman

Year: 2000

Topic(s):

Export Citation: RIS

View details

1820

Can enhanced acute-phase treatment of depression improve long-term outcomes? A report of randomized trials in primary care

Type: Journal Article

Authors: E. H. Lin, G. E. Simon, W. J. Katon, J. E. Russo, M. Von Korff, T. M. Bush, E. J. Ludman, E. A. Walker

Year: 1999

Topic(s):

Export Citation: RIS

View details